EFFECT OF AROMATASE INHIBITORS ON BONE MINERAL DENSITY IN PATIENTS WITH BREAST CANCER

被引：0
|
作者：
Khachidze, N. [1 ]
Giorgadze, E. [2 ]
Tsagareli, M. [3 ]
Dolidze, N. [2 ]
Sharikadze, N. [4 ]
Sulikashvili, T. [3 ]
Jeiranashvili, N. [3 ]
机构：
[1] Clin Curatio, Tbilisi, Georgia
[2] Natl Inst Endocrinol, Tbilisi, Georgia
[3] Natl Inst Endocrinol, Skeletal Endocrinol Unit, Tbilisi, Georgia
[4] Clin MediClub, Tbilisi, Georgia
来源：
OSTEOPOROSIS INTERNATIONAL | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P464
引用
收藏
页码：S237 / S238
页数：2
相关论文
共 50 条
  • [21] BONE MINERAL DENSITY AND MORPHOMETRIC VERTEBRAL DEFORMITIES IN POSTMENOPAUSAL WOMEN RECEIVING AROMATASE INHIBITORS FOR BREAST CANCER
    Maldonado-Romero, L. V.
    Ahijon-Lana, M.
    Velazquez-Arce, C.
    Sifuentes Giraldo, W. A.
    Martinez Janez, N.
    Vazquez Diaz, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1201 - 1201
  • [22] Use of aromatase inhibitors in patients with breast cancer is associated with deterioration of bone microarchitecture and density
    Nunes, Frederico Arthur Pereira
    de Farias, Maria Lucia Fleiuss
    Oliveira, Felipe Peres
    Neto, Leonardo Vieira
    Lima, Luis Felipe Cardoso
    Neto, Francisco de Paula Paranhos
    de Mendonca, Laura Maria Carvalho
    Madeira, Miguel
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2021, 65 (04): : 505 - 511
  • [23] ONE YEAR AROMATASE INHIBITORS TREATMENT EFFECT ON BONE MINERAL DENSITY: IS IT SIGNIFICANT?
    Barbu, C. G.
    Mocanu, D.
    Fica, S.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 : S358 - S358
  • [24] BONE MINERAL DENSITY IN PATIENTS WITH BREAST CANCER
    Erdemci, B.
    Ayan, A. K.
    Uzkeser, H.
    Orsal, E.
    Ozmen, H. K.
    Karatay, S.
    Yildirim, K.
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 : 685 - 685
  • [25] The effect of aromatase inhibitors on bone mineral density measured by serial DXA scans
    Whannel, K. J.
    Doughty, J. C.
    Wilson, C. R.
    McLellan, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [26] Vitamin D deficiency and bone mineral density in postmenopausal women receiving aromatase inhibitors for early breast cancer
    Nogues, Xavier
    Servitja, Sonia
    Jesus Pena, Maria
    Prieto-Alhambra, Daniel
    Nadal, Rosa
    Mellibovsky, Leonardo
    Albanell, Joan
    Diez-Perez, Adolfo
    Tusquets, Ignasi
    MATURITAS, 2010, 66 (03) : 291 - 297
  • [27] Bone Health History in Breast Cancer Patients on Aromatase Inhibitors
    Kwan, Marilyn L.
    Lo, Joan C.
    Tang, Li
    Laurent, Cecile A.
    Roh, Janise M.
    Chandra, Malini
    Hahn, Theresa E.
    Hong, Chi-Chen
    Sucheston-Campbell, Lara
    Hershman, Dawn L.
    Quesenberry, Charles P., Jr.
    Ambrosone, Christine B.
    Kushi, Lawrence H.
    Yao, Song
    PLOS ONE, 2014, 9 (10):
  • [28] Impact of aromatase inhibitors on bone health in breast cancer patients
    Geisler, Jurgen
    Lonning, Per E.
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2010, 118 (4-5): : 294 - 299
  • [29] A phase 3 study of the effect of denosumab therapy on bone mineral density in women receiving aromatase inhibitors for non metastatic breast cancer
    Ellis, G.
    Bone, H. G.
    Chlebowski, R.
    Paul, D.
    Spadafora, S.
    Smith, J.
    Fan, M.
    Jun, S.
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 109 (03) : 585 - 586
  • [30] Managing bone health in women with breast cancer under adjuvant treatment with aromatase inhibitors: pretreatment bone mineral density is important
    Markopoulos, Christos
    BREAST CANCER RESEARCH, 2010, 12 (04)
12345